As part of the Tolerance Induction Program, patients are placed on a low dose, over-the-counter antihistamine and/or nasal spray during part or all of active treatment. These medications are determined on a patient-by-patient basis and help to supplement the treatment process as we systematically introduce the patient’s allergens according to their unique protocol. Once the patient graduates from the program, and in some cases sooner, they no longer need to continue with these medications.
